CALLIE FAUST: Open Payments
NPI 1104500891 · HAVELOCK, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 29 payments from 16 companies in 2025. Trend: 2023 $15 · 2024 $96 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $143 |
| Madrigal Pharmaceuticals | 2 | $77 |
| Lilly USA, LLC | 4 | $61 |
| Averitas Pharma Inc. | 2 | $55 |
| BETA BIONICS, INC. | 2 | $43 |
| Sequel Med Tech, LLC | 1 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Ascensia Diabetes Care Us Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Eisai Inc. | 1 | $16 |
Products named: Kerendia, REZDIFFRA, MOUNJARO, QUTENZA, iLet Bionic Pancreas, TWIIST, VOQUEZNA, Cologuard Collection Kit.
Industry payments across NC — which companies pay providers there.
